Literature DB >> 17105567

Detection and distribution of probiotic Escherichia coli Nissle 1917 clones in swine herds in Germany.

S Kleta1, H Steinrück, G Breves, S Duncker, C Laturnus, L H Wieler, P Schierack.   

Abstract

AIMS: To verify the presence of Escherichia coli Nissle 1917 as a natural isolate in swine and to characterize in vitro probiotic properties as well as in vivo persistence in a feeding experiment. METHODS AND
RESULTS: During studies on the intestinal microflora of pigs, we isolated E. coli Nissle 1917 sporadically from a pig population over a period of 1 year. The identity of the isolates as E. coli Nissle 1917 was verified by serotyping, Nissle-specific PCR, macrorestriction analysis (pulsed field gel electrophoresis) and the determination of in vitro probiotic properties in invasion and adhesion assays using a porcine intestinal epithelial cell line. Both the E. coli isolates and the E. coli Nissle 1917 strain showed strong reductions in adhesion of porcine enteropathogenic E. coli and invasion of Salmonella typhimurium with epithelial cells in vitro, with a probiotic effect. Screening of five epidemiologically unlinked swine farms and two wild boar groups showed one farm positive for E. coli Nissle 1917. A feeding experiment with four piglets showed viable E. coli Nissle 1917 in the intestine of three animals.
CONCLUSIONS: The results of this study suggest that the E. coli Nissle 1917 strain is already partially established in swine herds, but the colonization of individual animals is variable. SIGNIFICANCE AND IMPACT OF THE STUDY: We report natural, long-term colonization and transmission of the probiotic E. coli Nissle 1917 strain in a swine herd, characterized individual persistence and colonization properties in swine and established an in vitro porcine intestinal epithelial cell model of probiotic action. The results of this study would have implications in the use of this strain as a probiotic in swine and contribute to a better understanding of the individual nature of intestinal bacterial persistence and establishment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105567     DOI: 10.1111/j.1365-2672.2006.03019.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  16 in total

1.  A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation.

Authors:  Rose A Whelan; Sebastian Rausch; Friederike Ebner; Dorothee Günzel; Jan F Richter; Nina A Hering; Jörg-Dieter Schulzke; Anja A Kühl; Ahmed Keles; Pawel Janczyk; Karsten Nöckler; Lothar H Wieler; Susanne Hartmann
Journal:  Mol Ther       Date:  2014-07-02       Impact factor: 11.454

2.  Experimental administration of the probiotic Escherichia coli strain Nissle 1917 results in decreased diversity of E. coli strains in pigs.

Authors:  David Smajs; Jan Bureš; Jan Smarda; Eva Chaloupková; Jaroslav Květina; Miroslav Förstl; Darina Kohoutová; Martin Kuneš; Stanislav Rejchrt; Jiřina Lesná; Marcela Kopáčová
Journal:  Curr Microbiol       Date:  2011-11-25       Impact factor: 2.188

3.  Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.

Authors:  Jan Bures; David Smajs; Jaroslav Kvetina; Miroslav Förstl; Jan Smarda; Darina Kohoutova; Martin Kunes; Jiri Cyrany; Ilja Tacheci; Stanislav Rejchrt; Jirina Lesna; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

4.  Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine.

Authors:  A Splichalova; I Trebichavsky; V Rada; E Vlkova; U Sonnenborn; I Splichal
Journal:  Clin Exp Immunol       Date:  2010-12-13       Impact factor: 4.330

5.  Guide to designing, conducting, publishing and communicating results of clinical studies involving probiotic applications in human participants.

Authors:  Andi L Shane; Michael D Cabana; Stéphane Vidry; Dan Merenstein; Ruben Hummelen; Collin L Ellis; James T Heimbach; Susanne Hempel; Susan V Lynch; Mary Ellen Sanders; Daniel J Tancredi
Journal:  Gut Microbes       Date:  2010-06-16

6.  Response of nursery pigs to a synbiotic preparation of starch and an anti-Escherichia coli K88 probiotic.

Authors:  D O Krause; S K Bhandari; J D House; C M Nyachoti
Journal:  Appl Environ Microbiol       Date:  2010-10-15       Impact factor: 4.792

7.  E. coli Nissle 1917 Affects Salmonella adhesion to porcine intestinal epithelial cells.

Authors:  Peter Schierack; Sylvia Kleta; Karsten Tedin; Julius Tachu Babila; Sibylle Oswald; Tobias A Oelschlaeger; Rico Hiemann; Susanne Paetzold; Lothar H Wieler
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

8.  Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection.

Authors:  Sylvia Kleta; Marcel Nordhoff; Karsten Tedin; Lothar H Wieler; Rafal Kolenda; Sibylle Oswald; Tobias A Oelschlaeger; Wilfried Bleiss; Peter Schierack
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

9.  Porcine E. coli: virulence-associated genes, resistance genes and adhesion and probiotic activity tested by a new screening method.

Authors:  Peter Schierack; Stefan Rödiger; Christoph Kuhl; Rico Hiemann; Dirk Roggenbuck; Ganwu Li; Jörg Weinreich; Enrico Berger; Lisa K Nolan; Bryon Nicholson; Antje Römer; Ulrike Frömmel; Lothar H Wieler; Christian Schröder
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

10.  Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10.

Authors:  Anke Zschüttig; Kurt Zimmermann; Jochen Blom; Alexander Goesmann; Christoph Pöhlmann; Florian Gunzer
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.